均匀共沉淀-水热法制备纤维状羟基磷酸钙/壳聚糖复合粉体

以尿素沉淀剂，运用溶液均匀共沉淀法制得纤维状羟基磷灰石(HAP)和无定形颗粒状守壳聚糖(CS)的复合粉体，通过水势处理调整纤维状HAP晶粒尺寸的大小，对粉体进行了XRD、TEM、IR及化学组成(Ca／P)表征。均匀一水热共沉淀过程中，pH值对粉体Ca／P、XRD、TEM、IR有很大影响。     

壳聚糖固定化脲酶的制备和废水中的尿素分析

流动注射;尿素测定;壳聚糖固定化脲酶的制备和废水中的尿素分析     

庆大霉素对羟基磷灰石/壳聚糖复合材料性能的影响

羟基磷灰石/壳聚糖-庆大霉素(HA/CS-G)缓释材料为骨髓炎的定点缓释给药提供了一种有效的局部药物缓释体系。为了研究抗生素对羟基磷灰石/壳聚糖材料性能的影响,采用共沉淀法制备了HA/CS-G缓释材料。利用红外光谱(IR)、X射线衍射(XRD)和扫描电子显微镜(SEM)对材料进行了表征。以不载药的羟基磷灰石/壳聚糖(HA/CS)为对照,研究了庆大霉素对HA/CS复合材料抑菌性能、力学性能和降解性能等的影响。实验结果表明,HA/CS-G有良好的抑菌效果。负载庆大霉素后HA/CS的机械强度明显增强,而材料的降解速率有所下降。本文采用的二次成型技术显著增大了材料的机械强度。     

(2-羟基-3-丁氧基)丙基-羧甲基壳聚糖的合成及表面性质

(2-羟基-3-丁氧基)丙基-羧甲基壳聚糖的合成及表面性质;壳聚糖衍生物; (羟基丁氧基)丙基-羧甲基壳聚糖;表面活性;表面压     

羟基中环二胺接枝壳聚糖的合成与表征

以具有环氧活性基的壳聚糖与3-羟基-1，5-二氮杂环庚烷或3-羟基1，5-二氮杂环辛烷反应，合成了两种含羟基的氮杂冠醚壳聚糖衍生物，其组成及结构经元素分析，IR，X-射线粉末衍射及^13C NMR等方法确证。     

可降解聚乳酸/羟基磷灰石杂化材料Ⅰ.纳米羟基磷灰石的合成

可降解聚乳酸/羟基磷灰石杂化材料Ⅰ.纳米羟基磷灰石的合成;化学共沉淀;共沸蒸馏;纳米羟基磷灰石;表面处理剂     

原位合成羟基磷灰石/壳聚糖复合吸附剂及除氟特性研究

利用原位共沉淀法合成了羟基磷灰石/壳聚糖复合吸附剂,通过扫描电镜、X射线粉末衍射、红外光谱和N2吸附-脱附曲线,研究复合前后羟基磷灰石的理化特征变化。实验结果表明与壳聚糖复合后羟基磷灰石的晶型并没有改变,只是结晶度有所降低,且复合后表面形成了不规则的凹凸结构,表面粗糙度增加。比表面积从106.75m2/g增加到127.58m2/g。复合吸附剂孔径大部分集中在10~50nm,属于介孔结构。利用Langmuir和Freundlich吸附等温方程对实验数据进行了拟合,对比相关系数R2值,Langmuir模型能更好地描述该吸附过程。复合吸附剂对氟离子的吸附符合拟二级反应动力学方程。计算了吸附热力学和动力学参数值,探讨了复合吸附剂对氟离子的吸附机理。ΔG0<0、ΔH0>0和ΔS0>0,说明复合吸附剂对氟离子的吸附是自发的、吸热的熵增过程,温度升高有利于吸附。吸附活化能(Ea)=15.03kJ·mol-1,迁移能(E)=7.639kJ·mol-1,说明该吸附过程以物理吸附为主。     

原位复合法制备层状结构的壳聚糖/羟基磷灰石纳米材料

用原位复合法制备了高性能的壳聚糖/羟基磷灰石(CS/HA)纳米复合材料.用预先沉积的壳聚糖膜将含有羟基磷灰石前驱体的壳聚糖溶液与凝固液隔离,同时控制壳聚糖沉积与羟基磷灰石前驱体转化为羟基磷灰石的过程,使其缓慢且有序地进行.当pH值改变时,质子化的壳聚糖分子链在负电层诱导下有序沉积并形成层状结构与羟基磷灰石原位生成CS/HA,并实现二者分子级复合.XRD和TEM测试证实原位生成的磷酸盐是羟基磷灰石,且其颗粒长约为100nm,宽30～50nm.SEM结果表明,用原位复合法制备的材料具有层状结构,CS/HA(质量比100/5)纳米复合材料弯曲强度高达86MPa,比松质骨的高3～4倍,相当于密质骨的1/2,有望用于可承重部位的组织修复材料.     

pva-sa/cs双极膜制备及在电解制备羟基新戊酸中的应用

双极膜;羟基新戊酸;电氧化;海藻酸钠;壳聚糖;聚乙烯醇     

羧甲基壳聚糖衍生物及其振动光谱的理论研究

用量子化学从头算STO 3G法研究了羧甲基壳聚糖及其衍生物的结构和稳定性，计算结果表明:1)壳聚糖单体经羧甲基化后，得到2种可能的产物，其中羧甲基在壳聚糖单体2位氨基上的取代产物较6位羟基上的取代产物稳定； 2)以羧甲基壳聚糖为母体经加成反应，得到羧甲基壳聚糖衍生物（2 羟基 3 丁氧基）丙基 羧甲基壳聚糖的2个异构体， 其中构型1更稳定.在优化构型的基础上，计算所得的构型1的振动光谱与实验结果相吻合.     

Synthesis and characterization of magnesium substituted biphasic mixtures of controlled hydroxyapatite/β-tricalcium phosphate ratios

The present paper investigates the preparation of magnesium (Mg) substituted biphasic mixtures of different hydroxyapatite (HAP)/β-tricalcium phosphate (β-TCP) ratios through aqueous precipitation method. The concentrations of added magnesium (Mg) were varied with the calcium in order to obtain constant (Ca+Mg)/P ratios of 1.67 ranging from 1.62+0.05, 1.58+0.09 and 1.54+0.13, respectively. The as prepared powders were calcined at different temperatures to study the phase behaviour and thermal stability. The powders were characterized by the following analytical techniques: TG-DTA, X-ray diffraction and FT-IR. The results have shown that substitution of Mg in the calcium-deficient apatites resulted in the formation of biphasic mixtures of different HAP/β-TCP ratios after heating above 700 °C. The ratios of the formation of phase mixtures were dependent on the calcium deficiency in the apatites with the higher deficiency having the strongest impact on the increased formation of β-TCP and the substituted Mg was found to stabilize the β-TCP phase.     

Porous composite scaffolds of hydroxyapatite/silk fibroin via two‐step method

A two‐step method was used to fabricate the hydroxyapatite (HAP)/silk fibroin (SF) scaffolds, i.e. the nano‐sized HAP/SF composite powders were prepared by co‐precipitation, which were then blended with SF solution to fabricate the HAP/SF composite scaffolds. The obtained scaffolds showed a 3D porous structure. The porosity was higher than 90% with the average macropore size of 214.2 µm. Moreover, the nano‐sized HAP/SF composite powders were uniformly dispersed in the silk fibroin matrix, which provided the scaffolds enhanced compressive properties. The cell culture assay showed that the scaffolds fabricated by the two‐step method could improve the cell proliferation and osteogenic differentiation when compared with those prepared by the conventional one‐step blending method. The results suggested that the two‐step method could promote the uniform dispersion of HAP in the SF matrix and efficient combination between the HAP and the matrix, which may provide a potential application in the composite scaffold preparation for tissue engineering. Copyright © 2009 John Wiley & Sons, Ltd.     

水热电沉积羟基磷灰石涂层的研究

在0.0105mol/LCa(NO₃)₂,0.0063mol/LNH₄H₂PO₄,0.1mol/LNaNO₃,pH=4.6的电解液中,控制温度60～200℃,恒电流0.4mA/cm²,通过水热电沉积法制备羟基磷灰石涂层.实验结果表明,涂层晶体端面呈六边形棒状结构,涂层组分为缺钙磷灰石Ca_10-x(HPO₄)_x(PO₄)_6-x(OH)_2-x.经800℃烧结后涂层分解为HA和β-TCP的混合物.随温度升高,涂层n(Ca)/n(P)不断增大,涂层组分逐渐接近计量比的HA.涂层质量和结合强度随温度升高先增后减,在160℃时达到最大值16.7MPa     

羟基磷灰石/丝素蛋白复合纤维的制备及其矿化研究

在以静电纺丝法制备羟基磷灰石(HAP)/丝素蛋白(SF)复合纤维的前提下, 采用同轴共纺法获得了以HAP为“芯”、SF为“皮”的双组分电纺纤维(电纺膜), 并通过扫描和透射电镜、红外光谱以及X射线衍射等手段对电纺纤维进行了表征. 结果表明, HAP均存在于上述两种方法制备的纳米纤维中, 但同轴共纺法不仅可以避免HAP/SF共混电纺时pH值对丝素蛋白结构的影响, 并且能大大提高电纺膜中HAP的含量. 同时, 我们还分别以SF纤维、HAP/SF复合纤维和HAP/SF“皮-芯”纤维作为有机基质, 对羟基磷灰石在其上的矿化过程进行了探索, 结果表明含较多羟基磷灰石的HAP/SF“皮-芯”纤维更有利于矿化的进行.     

磷酸化壳聚糖膜的仿生复合修饰

仿生构建羟基磷灰石/壳聚糖复合材料是制备骨修复材料的一条有效途径.以甲醛和磷酸为反应试剂,采用均相反应法制备出壳聚糖(CS)的磷酸化衍生物-甲基磷酸化壳聚糖(NPCS).红外光谱、X射线光电子能谱分析结果表明,改性后的CS分子结构和元素组成发生显著变化,偶合等离子体发射光谱测试显示NPCS的取代度可达到0.5左右.用模拟体液(SBF)处理CS和NPCS膜,扫描电镜(SEM)观察和能量色散X射线分析表明,NPCS膜表面沉积了磷酸钙盐.由X射线衍射分析得知,NPCS膜表面形成的是低结晶度的羟基磷灰石(HA).接触角测试结果表明,经改性或修饰后,材料表面的亲水性明显提高.     

原位沉析法制备磁性氧化铁羟基磷灰石/壳聚糖棒材

首先通过化学沉淀法制备磁性氧化铁羟基磷灰石(Fe3O4/HA),然后以壳聚糖(CS)为基体,利用原位沉析法将Fe3O4/HA与CS复合,制得磁性Fe3O4/HA/CS复合材料.经XRD、粒径分布和PPMS测试,结果表明了Fe3O4/HA复合物的生成.系统研究了磁性Fe3O4/HA/CS棒材力学性能的影响因素,最终确定Fe3O4与HA质量比为3∶17,磁性Fe3O4/HA与CS质量比为9∶91时,棒材的力学性能最优,弯曲强度可达到87.0 MPa,弯曲模量1.57 GPa.     

Synthesis and characterization of a nano‐hydroxyapatite/chitosan/polyethylene glycol nanocomposite for bone tissue engineering

A novel nanocomposite involving nano‐hydroxyapatite/chitosan/polyethylene glycol (n‐HAP/CS/PEG) has been successfully synthesized via co‐precipitation approach at room temperature. The purpose to synthesize such nanocomposite is to search for an ideal analogue which may mimick the composition of natural bone for bone tissue engineering with respect to suitable biocompatibility, cytotoxicity and mechanical properties. The FTIR spectra of n‐HAP/CS and n‐HAP/CS/PEG scaffolds indicated significant intermolecular interaction between the various components of both the nanocomposites. The results of XRD, TEM and TGA/DTA suggested that the crystallinity and thermal stability of the n‐HAP/CS/PEG scaffold have decreased and increased respectively, relative to n‐HAP/CS scaffold. The comparison of SEM images of both the scaffolds indicated that the incorporation of PEG influenced the surface morphology while a better in‐vitro bioactivity has been observed in n‐HAP/CS/PEG than in n‐HAP/CS based on SBF study, referring a greater possibility for making direct bond to living bone if implanted. Furthermore, MTT assay revealed superior non‐toxic nature of n‐HAP/CS/PEG to murine fibroblast L929 cells as compared to n‐HAP/CS. The comparative swelling studies of n‐HAP/CS/PEG and n‐HAP/CS scaffolds revealed a better swelling rate for n‐HAP/CS/PEG. Also n‐HAP/CS/PEG showed higher mechanical strength relative to n‐HAP/CS supportive of bone tissue ingrowths. Copyright © 2014 John Wiley & Sons, Ltd.     

Spectroscopic characterization of porous nanohydroxyapatite synthesized by a novel amino acid soft solution freezing method

In this paper, we have reported a novel method to synthesize nanoporous hydroxyapatite (HAP) powders by freezing organic–inorganic soft solutions. The formation of porous and crystalline HAP nanopowder was achieved via calcining the samples at 600 °C followed by sintering at temperatures ranging from 900 °C to 1100 °C. The samples were analyzed by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopic (SEM) techniques. The results showed the formation of a carbon free nanoporous hydroxyapatite powders due to the decomposition of organic template enclosing the precipitated HAP. It was also observed that the rapid grain growth with retainment of pores while the crystallinity of the HAP nanopowder increased with the increase in sintering temperature which is substantiated from the XRD and SEM results. Such organized porous materials can act as a better biomaterial for bone tissue engineering.     

FTIR and NMR study of poly(lactide-co-glycolide) and hydroxyapatite implant degradation under in vivo conditions

The influence of hydroxyapatite (HAP) addition on the rate and mechanism of lactide-co-glycolide copolymer (PGLA) degradation after implantation (in vivo study) was analyzed and compared with the process taking place during in vitro studies. Structural and phase changes of poly(lactide-co-glycolide) and its composite with hydroxyapatite were determined using IR and NMR spectroscopy.Degradation of PGLA and PGLA + HAP composite in biological environment proceeds faster than under in vitro condition. Concentration of glycolidyl units in the copolymer chain decreases and that of lactidyl units increases during in vivo degradation both, in PGLA and in PGLA + HAP composite. However, in the case of the composite the decrease of glycolidyl units concentration is slower and after 6 weeks of degradation the contents of lactidyl and glycolidyl units remain stable. On the other hand, PGLA + HAP composite degrades faster than pure PGLA. The addition of HAP nanoparticles distinctly accelerates degradation of PGLA copolymer which is probably connected with the increase of hydrophilicity of the composite and inhibition of semi-crystalline lactidyl domains formation during the degradation process. Observation of the bone tissue after implantation of PGLA + HAP allows to conclude that the degradation of the composite occurs simultaneously with the implant replacement by the bone cells.